Introduction
Oproxy is a prescription medication that contains the active ingredients Proparacaine and Chlorbutol. It is commonly used in ophthalmology to provide temporary relief from eye discomfort and pain.
Uses
Oproxy is primarily prescribed to numb the surface of the eye during ophthalmic procedures such as eye examinations or surgeries. It helps to alleviate pain and discomfort by temporarily blocking the nerve signals in the eye.
Dosage and Administration
The dosage and administration of Oproxy should be determined by your healthcare professional. Typically, a single drop of the medication is instilled into the affected eye(s) just before the procedure. Follow the instructions provided by your doctor or pharmacist carefully.
Mechanism of Action
The active ingredients in Oproxy work together to produce a numbing effect on the surface of the eye. Proparacaine is a local anesthetic that blocks the transmission of pain signals by inhibiting the function of nerve endings in the eye. Chlorbutol acts as a preservative in the formulation to help maintain the stability of the medication.
Side Effects
Common side effects may include temporary stinging or burning sensation in the eye after application. These effects are usually mild and transient. However, if you experience any severe or persistent side effects, such as eye redness, swelling, or vision changes, seek medical attention immediately.
Drug Interactions
inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. There are no known significant drug interactions associated with Oproxy. However, it is always best to consult with your healthcare provider to ensure that it is safe to use this medication alongside any other medications you may be taking.
Precautions
Before using Oproxy, inform your healthcare professional if you have any known allergies to local anesthetics or any other substances. Additionally, let your doctor know if you have any pre-existing eye conditions or if you are pregnant or breastfeeding. Oproxy should be used with caution in patients with certain medical conditions, such as glaucoma or corneal abrasions. Follow your healthcare professional’s advice and instructions for safe and effective use.
Storage
Oproxy should be stored at room temperature, away from direct sunlight and heat sources. Keep the bottle tightly closed when not in use. Do not freeze the medication. Keep all medications out of the reach of children.
Patient Tips
- Wash your hands before and after using Oproxy to prevent the spread of infection.
- Use the medication exactly as prescribed by your healthcare professional and do not exceed the recommended dosage.
- If you wear contact lenses, remove them before using the eye drops and wait at least 15 minutes before reinserting them.
- Avoid touching the tip of the dropper to any surface to prevent contamination.
- If you experience any allergic reactions or other unexpected symptoms, discontinue use and contact your healthcare professional.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Chlorobutanol (International database) (Drugs.com) [Accessed 1 Jun. 2024] (online) Available at:
- Borody T, Chinwah PM, Graham GG, Wade DN, Williams KM. Chlorbutol toxicity and dependence. Med J Aust. 1979 Apr 7;1(7):288. doi: 10.5694/j.1326-5377.1979.tb112109.x. [Accessed 24 Jun. 2024] Available at:
- Sequeira SJ, McKenna TJ. Chlorbutol, a new inhibitor of aldosterone biosynthesis identified during examination of heparin effect on aldosterone production. J Clin Endocrinol Metab. 1986 Sep;63(3):780-4. doi: 10.1210/jcem-63-3-780. [Accessed 24 Jun. 2024] Available at:
- Proparacaine Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 26 Jun. 2024] (online) Available at:
Reviews
There are no reviews yet.